Key Points
- Omada Health CEO Sean Duffy sold 25,886 shares on July 1 at an average price of $22.68, totaling about $587,094. After the sale, he still held 411,861 shares valued at roughly $9.34 million.
- The stock was trading higher, opening at $22.85 and up 2.1% on the day, while remaining near its 52-week high of $26.92. Its 50-day and 200-day moving averages were $17.49 and $15.15, respectively.
- Analysts remain broadly positive on Omada Health, with an average rating of “Moderate Buy” and an average price target of $22.91. Recent reports included rating upgrades and price targets as high as $28.00.
Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) CEO Sean Duffy sold 25,886 shares of the firm's stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $22.68, for a total value of $587,094.48. Following the transaction, the chief executive officer owned 411,861 shares of the company's stock, valued at $9,341,007.48. The trade was a 5.91% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Omada Health Trading Up 2.1%
Shares of NASDAQ OMDA opened at $22.85 on Tuesday. Omada Health, Inc. has a 52-week low of $10.28 and a 52-week high of $26.92. The firm's 50 day moving average price is $17.49 and its 200-day moving average price is $15.15.
Omada Health (NASDAQ:OMDA - Get Free Report) last posted its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.08) by $0.03. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%.The firm had revenue of $78.05 million during the quarter. As a group, research analysts expect that Omada Health, Inc. will post -0.01 earnings per share for the current year.
Analysts Set New Price Targets
A number of analysts have recently issued reports on the stock. Citigroup reaffirmed an "outperform" rating on shares of Omada Health in a report on Friday, May 8th. Citizens Jmp lifted their target price on shares of Omada Health from $18.00 to $21.00 and gave the stock a "market outperform" rating in a research report on Friday, May 8th. Needham & Company LLC reissued a "buy" rating and set a $28.00 price target on shares of Omada Health in a report on Friday, May 8th. Wall Street Zen upgraded Omada Health from a "hold" rating to a "buy" rating in a research note on Saturday, June 27th. Finally, Evercore reiterated an "outperform" rating and set a $20.00 price objective on shares of Omada Health in a research report on Friday, May 8th. Ten analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $22.91.
Get Our Latest Stock Report on Omada Health
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently modified their holdings of the business. Quarry LP purchased a new stake in shares of Omada Health in the 4th quarter worth $29,000. TD Waterhouse Canada Inc. purchased a new stake in Omada Health in the 4th quarter worth approximately $32,000. Raymond James Financial Inc. bought a new stake in Omada Health during the 2nd quarter worth approximately $32,000. Inlight Wealth Management LLC bought a new position in shares of Omada Health in the fourth quarter worth approximately $45,000. Finally, Versant Capital Management Inc increased its stake in shares of Omada Health by 319.3% in the second quarter. Versant Capital Management Inc now owns 2,998 shares of the company's stock worth $66,000 after purchasing an additional 2,283 shares in the last quarter.
About Omada Health
(
Get Free Report)
Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company's platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.
In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
